Primary biliary cholangitis (PBC) has typically been considered a rare condition, with a pooled global estimated incidence of ...
Gilead Sciences, Inc. today announced data from a two-and-a-half-year interim analysis from the ongoing Phase 3 ASSURE study, which showed that 81% (30 out of 37) of participants with primary biliary ...
Ipsen presents 3 late-breaking presentations and 8 abstracts across rare cholestatic liver disease portfolio at AASLD 2024Iqirvo approved for use in the U.S. in June 2024, in the E.U. in September 202 ...
Target patient enrollment of 92 evaluable patients achieved in the VIRAGE Phase 2b clinical trial of VCN-01 in patients with metastatic ...
GERD (Gastro-Esophageal Reflux Disease) is pervasive. If you have heartburn or “mini-vomits,” you likely have GERD. I’ve ...
Nov. 12, 2024 (GLOBE NEWSWIRE) -- Theriva Biologics (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high ...
Complete Gardening on MSN4d
Where to Plant Hydrangeas: The Right Side of Your House MattersWhat if the secret to jaw-dropping hydrangeas isn’t just in the soil or water, but in where you plant them? Picture your ...
In an age where oral health is paramount, GumAktiv emerges as a revolutionary product designed to support your dental ...
By monitring upstream watersheds, Michigan expects to give farmers a better idea of where farm runoff is transporting ...
The FDA informed Intercept that it is unable to approve the sNDA in its current form, consistent with the outcome of the Gastrointestinal Drugs Advisory Committee (GIDAC) meeting in September 2024. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback